Thus, while CT-1 is considered a good biomarker in hypertensive patients for monitoring the cardiac dysfunction, FD patients develop hypertension differently, probably not involving the CT-1 mediated pathway. This evidence concerns the gene CTF1 and hypertensive disorder.